Kei Kunimasa, M., Jiro Okami, M., Satoshi Takenaka, M., Keiichiro Honma, M., Yoji Kukita, P., Shigenori Nagata, M., . . . Toru Kumagai, M. (2021). Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report. Elsevier.
Cita Chicago Style (17a ed.)Kei Kunimasa, MD, et al. Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report. Elsevier, 2021.
Cita MLA (8a ed.)Kei Kunimasa, MD, et al. Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report. Elsevier, 2021.